Invesco Ltd. Amphastar Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 332,925 shares of AMPH stock, worth $14.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

332,925

Previous 450,930 26.17%

Holding current value

$14.7 Million

Previous $18 Million 10.43%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$36.99 - $50.09 $4.37 Million - $5.91 Million	-118,005 Reduced 26.17%	332,925 $16.2 Million
Q2 2024 Aug 13, 2024	BUY	$38.65 - $43.48 $1.85 Million - $2.08 Million	47,890 Added 11.88%	450,930 $18 Million
Q1 2024 May 14, 2024	BUY	$42.85 - $63.45 $92,170 - $136,480	2,151 Added 0.54%	403,040 $17.7 Million
Q4 2023 Feb 12, 2024	SELL	$44.49 - $62.93 $433,332 - $612,938	-9,740 Reduced 2.37%	400,889 $24.8 Million
Q3 2023 Nov 13, 2023	SELL	$45.51 - $65.0 $6.83 Million - $9.75 Million	-150,045 Reduced 26.76%	410,629 $18.9 Million
Q2 2023 Aug 11, 2023	SELL	$35.77 - $58.38 $1.15 Million - $1.87 Million	-32,095 Reduced 5.41%	560,674 $32.2 Million
Q1 2023 May 12, 2023	SELL	$27.99 - $37.92 $1.49 Million - $2.02 Million	-53,190 Reduced 8.23%	592,769 $22.2 Million
Q4 2022 Feb 13, 2023	BUY	$27.93 - $31.27 $1.62 Million - $1.81 Million	58,016 Added 9.87%	645,959 $18.1 Million
Q3 2022 Nov 14, 2022	BUY	$27.56 - $37.75 $2.15 Million - $2.94 Million	77,896 Added 15.27%	587,943 $16.5 Million
Q2 2022 Aug 15, 2022	SELL	$29.79 - $42.29 $6.67 Million - $9.46 Million	-223,795 Reduced 30.5%	510,047 $17.7 Million
Q1 2022 May 16, 2022	BUY	$22.96 - $36.45 $848,440 - $1.35 Million	36,953 Added 5.3%	733,842 $26.3 Million
Q4 2021 Feb 14, 2022	SELL	$18.14 - $23.29 $316,180 - $405,944	-17,430 Reduced 2.44%	696,889 $16.2 Million
Q3 2021 Nov 15, 2021	SELL	$17.83 - $21.49 $1.32 Million - $1.59 Million	-74,095 Reduced 9.4%	714,319 $13.6 Million
Q2 2021 Aug 17, 2021	SELL	$17.11 - $20.92 $2.48 Million - $3.04 Million	-145,232 Reduced 15.56%	788,414 $15.9 Million
Q1 2021 May 17, 2021	SELL	$17.21 - $20.65 $7.94 Million - $9.53 Million	-461,401 Reduced 33.07%	933,646 $17.1 Million
Q4 2020 Feb 16, 2021	BUY	$17.76 - $21.24 $792,628 - $947,941	44,630 Added 3.3%	1,395,047 $28.1 Million
Q3 2020 Nov 16, 2020	BUY	$17.99 - $22.22 $1.47 Million - $1.81 Million	81,540 Added 6.43%	1,350,417 $25.3 Million
Q2 2020 Aug 14, 2020	BUY	$14.25 - $22.46 $7.51 Million - $11.8 Million	526,730 Added 70.97%	1,268,877 $28.5 Million
Q1 2020 May 15, 2020	SELL	$12.66 - $20.08 $4.54 Million - $7.21 Million	-358,845 Reduced 32.59%	742,147 $11 Million
Q4 2019 Feb 14, 2020	BUY	$17.07 - $20.64 $7.27 Million - $8.79 Million	426,012 Added 63.11%	1,100,992 $21.2 Million
Q3 2019 Nov 14, 2019	BUY	$19.12 - $22.62 $7.55 Million - $8.94 Million	395,073 Added 141.14%	674,980 $13.4 Million
Q2 2019 Aug 14, 2019	SELL	$18.92 - $22.96 $11.1 Million - $13.5 Million	-586,878 Reduced 67.71%	279,907 $5.91 Million
Q1 2019 May 15, 2019	SELL	$19.46 - $25.28 $4.79 Million - $6.22 Million	-246,082 Reduced 22.11%	866,785 $17.7 Million
Q4 2018 Feb 14, 2019	BUY	$17.72 - $22.51 $19.7 Million - $25.1 Million	1,112,867 New	1,112,867 $22.1 Million

Others Institutions Holding AMPH

# of Institutions

287

Shares Held

35.1M

Call Options Held

74.3K

Put Options Held

22.3K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $2.17B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account